Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises

Apr 28, 2022 · Eli Lilly (LLY) beats first-quarter estimates for both earnings and sales and ups its sales outlook for 2022. The stock rises in pre-market trading.

63%
OFF

Eli Lilly (LLY) Beats On Q1 Earnings, Ups Sales View, Stock Rises

2 weeks from now

Apr 28, 2022 · Eli Lilly and Company LLY reported first-quarter 2022 adjusted earnings per share of $2.62, which beat the Zacks Consensus Estimate of $2.32. Earnings rose 63% year over …

nasdaq.com

$2.58
OFF

Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised

2 weeks from now

Apr 30, 2024 · Eli Lilly and Company LLY reported first-quarter 2024 adjusted earnings per share (“EPS”) of $2.58, which beat the Zacks Consensus Estimate of $2.53 per share. Earnings rose …

yahoo.com

24%
OFF

Eli Lilly's Q1: Another Quarter Of Strong Growth

2 weeks from now

Apr 30, 2024 · Eli Lilly (LLY-0.24%), a leading pharmaceutical company, released its Q1 financials on April 30, and the numbers showcased a robust performance that exceeded expectations on …

fool.com

$2.34
OFF

Eli Lilly And Co. Q1 Profit Increases, Beats Estimates - Nasdaq

2 weeks from now

Apr 30, 2024 · Excluding items, Eli Lilly And Co. reported adjusted earnings of $2.34 billion or $2.58 per share for the period. Analysts on average had expected the company to earn $2.46 …

nasdaq.com

$13
OFF

Eli Lilly Stock Slumps On Lowered Sales Forecast - Investopedia

2 weeks from now

4 hours ago · Eli Lilly said it expects fourth-quarter revenue of roughly $13.5 billion, which would bring full-year revenue to $45 billion, lower than the $45.4 billion to $46 billion range the …

investopedia.com

$2.58
OFF

Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised

2 weeks from now

Apr 30, 2024 · Eli Lilly and Company (LLY Quick Quote LLY - Free Report) reported first-quarter 2024 adjusted earnings per share (“EPS”) of $2.58, which beat the Zacks Consensus Estimate …

zacks.com

7%
OFF

Eli Lilly Shares Tumble After Cutting Its Sales Outlook. What It Means ...

2 weeks from now

4 hours ago · Shares plunged 7% after management said demand for its popular GLP-1 drugs did not meet expectations.

cnbc.com

1%
OFF

LLY Stock Rises As Pharma Giant Crushes First-Quarter …

2 weeks from now

Apr 23, 2020 · On the stock market today, LLY stock rose 2.1%, to 159.93. LLY Stock Rises On Earnings Beat For the first quarter ended March 31, adjusted Lilly earnings were $1.75 a share …

investors.com

0%
OFF

Grove Church Cemetery - Find A Grave

2 weeks from now

Double click on map to view more. 0% Complete. Saved. Search Tips. When searching in a cemetery, use the ? or * wildcards in name fields. ? replaces one letter. * represents zero to …

findagrave.com

FAQs about Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises Coupon?

How did Eli Lilly & Company (LLY) perform in first-quarter 2023?

Eli Lilly and Company LLY reported first-quarter 2023 adjusted earnings per share of $1.62, which missed the Zacks Consensus Estimate of $1.73 and just fell shy of our model estimate of $1.63. Earnings declined 38% year over year on the back of higher operating expenses. ...

How did Eli Lilly perform in first-quarter 2022?

Eli Lilly and Company LLY reported first-quarter 2022 adjusted earnings per share of $2.62, which beat the Zacks Consensus Estimate of $2.32. Earnings rose 63% year over year, driven by higher operating profits. Revenues of $7.81 billion also beat the Zacks Consensus Estimate of $7.52 billion. Sales increased 15% year over year. ...

Is Eli Lilly (LLY) a good stock to buy?

Eli Lilly (LLY) beats first-quarter estimates for both earnings and sales and ups its sales outlook for 2022. The stock rises in pre-market trading. ...

How will Eli Lilly & company's earnings perform next year?

Quarterly revenue rose 20.4% year-over-year to $11.44 billion, below analyst estimates of $12.09 billion. With a trailing EPS of $9.25 and a P/E Ratio of 81.84, Eli Lilly and Company's earnings are expected to grow 79.29% next year, from $13.18 to $23.63 per share. Want to stay updated on the latest earnings announcements and upcoming reports? ...

How did Eli Lilly perform in Q1?

Eli Lilly's earnings exceeded estimates, powered by significant sales growth despite supply issues. Eli Lilly ( LLY 5.72%), a leading pharmaceutical company, released its Q1 financials on April 30, and the numbers showcased a robust performance that exceeded expectations on the earnings front. ...

How much did Eli Lilly & Co earn in the first quarter?

The company's earnings totaled $2.24 billion, or $2.48 per share. This compares with $1.34 billion, or $1.49 per share, in last year's first quarter. Excluding items, Eli Lilly And Co. reported adjusted earnings of $2.34 billion or $2.58 per share for the period. ...